Veru Inc Dl 01 Stock Fundamentals
| FMW Stock | EUR 0.62 0.03 4.62% |
VERU INC DL 01 fundamentals help investors to digest information that contributes to VERU INC's financial success or failures. It also enables traders to predict the movement of VERU Stock. The fundamental analysis module provides a way to measure VERU INC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VERU INC stock.
VERU |
VERU INC DL 01 Company Profit Margin Analysis
VERU INC's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current VERU INC Profit Margin | (2.13) % |
Most of VERU INC's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VERU INC DL 01 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, VERU INC DL 01 has a Profit Margin of -2.1288%. This is 81.01% lower than that of the Healthcare sector and 90.76% lower than that of the Biotechnology industry. The profit margin for all Germany stocks is 67.62% higher than that of the company.
VERU INC DL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VERU INC's current stock value. Our valuation model uses many indicators to compare VERU INC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VERU INC competition to find correlations between indicators driving VERU INC's intrinsic value. More Info.VERU INC DL 01 is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VERU INC's earnings, one of the primary drivers of an investment's value.VERU Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VERU INC's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VERU INC could also be used in its relative valuation, which is a method of valuing VERU INC by comparing valuation metrics of similar companies.VERU INC is currently under evaluation in profit margin category among its peers.
VERU Fundamentals
| Return On Equity | -0.72 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (2.13) % | |||
| Operating Margin | (2.11) % | |||
| Shares Outstanding | 80.62 M | |||
| Shares Owned By Insiders | 19.22 % | |||
| Shares Owned By Institutions | 49.02 % | |||
| Price To Earning | 381.84 X | |||
| Revenue | 39.35 M | |||
| Gross Profit | 30.59 M | |||
| EBITDA | (83.01 M) | |||
| Net Income | (476.2 K) | |||
| Cash And Equivalents | 136.68 M | |||
| Cash Per Share | 1.72 X | |||
| Total Debt | 15.25 M | |||
| Debt To Equity | 0.1 % | |||
| Current Ratio | 8.27 X | |||
| Book Value Per Share | 1.00 X | |||
| Cash Flow From Operations | 1.07 M | |||
| Earnings Per Share | (0.33) X | |||
| Target Price | 24.4 | |||
| Number Of Employees | 233 | |||
| Beta | -0.27 | |||
| Market Capitalization | 425.09 M | |||
| Z Score | 16.2 |
About VERU INC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VERU INC DL 01's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VERU INC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VERU INC DL 01 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. VERU INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3 people.
Currently Active Assets on Macroaxis
Other Information on Investing in VERU Stock
VERU INC financial ratios help investors to determine whether VERU Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VERU with respect to the benefits of owning VERU INC security.